Insurance coverage for new weight loss medications, such as GLP-1 agonists, varies by plan, though some large employers are starting to include these treatments in their coverage options
NHS and NICE-recommended weight management approaches including structured lifestyle interventions, behavioural support, and where appropriate, licensed pharmacological treatments such as orlistat or GLP-1 receptor agonists have a substantially stronger evidence base than L-carnitine supplements
Important Safety Info for GLP-1s See Important Safety Information, including Boxed Warning, about: Important Safety Information for Wegovy (semaglutide) injection Warning: Risk of Thyroid C-Cell Tumors In studies with mice and rats, semaglutide (the active ingredient in Wegovy and Ozempic) caused thyroid tumors, including thyroid cancer
Finan B, Yang B, Ottaway N, Stemmer K, Mller TD, Yi C-X, et al
Most people see changes on the scale after 2 to 4 weeks